Compound Detail
CHEMBL239180
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL239180 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DDMVVUOZEZSZKY-UHFFFAOYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
357.6
MW (Da)
5.10
ALogP
3
HBA
1
HBD
38.9
PSA (Ų)
0.66
QED
1
Ro5 Violations
1
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.24
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Ephrin type-B receptor 4 CHEMBL5147 | IC50 | 6.24 | 6.24 | 575.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Ephrin type-B receptor 4 | IC50 | = | 575.0 | nM | 6.24 | Inhibition of human EphB4 by scintillation proximity method | 17027260 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 17027260 | 10.1016/j.bmcl.2006.09.050 | Ephrin type-B receptor 4 | 2 |
Data from ChEMBL 36 via Core Engine